Pregnant women who are taking antidepressants are at a 68% greater risk for miscarriage than women not taking the drugs, a nested, case-control study from Quebec reports.
Pregnant women who are taking antidepressants are at a 68% greater risk for miscarriage than women not taking the drugs, a nested, case-control study from Quebec reports.
Researchers included data on 5,124 women who had had clinically verified miscarriages up to 20 weeks' gestation and a large sample of women who had not miscarried. Of those who miscarried, 5.5% had taken at least 1 antidepressant during the pregnancy versus 2.7% of those who did not.
Use of a selective serotonin reuptake inhibitor increased the risk by about 61% (odds ratio [OR]. 1.61; 95% CI, 1.28-2.04). Serotonin-norepinephrine reuptake inhibitors more than doubled the risk (OR, 2.11; 95% CI, 1.34-3.30). Further, combined use of more than 1 antidepressant from different classes more than tripled the risk (OR, 3.51; 95% CI 2.20-5.61). The risk of miscarriage associated with use of these categories of antidepressants was significantly higher than with solo therapy with tricyclic antidepressants or other classes of antidepressants (adjusted OR, 1.27-1.53; P<.05).
Chemoattractants in fetal membranes enhance leukocyte migration near term pregnancy
November 22nd 2024A recent study highlights the release of chemoattractants from human fetal membranes at term, driving leukocyte activation and migration, with implications for labor and postpartum recovery.
Read More
Reproductive genetic carrier screening: A tool for reproductive decision-making
November 22nd 2024A new study highlights the efficacy of couple-based reproductive genetic carrier screening in improving reproductive decisions and outcomes, emphasizing its growing availability and acceptance among diverse populations.
Read More
Early preterm birth risk linked to low PlGF levels during pregnancy screening
November 20th 2024New research highlights that low levels of placental growth factor during mid-pregnancy screening can effectively predict early preterm birth, offering a potential tool to enhance maternal and infant health outcomes.
Read More